Stocks and Investing Stocks and Investing
Thu, February 18, 2021
Wed, February 17, 2021

Serge Belanger Maintained (VRCA) at Strong Buy with Increased Target to $22 on, Feb 17th, 2021


Published on 2024-10-27 15:39:54 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy with Increased Target from $17 to $22 on, Feb 17th, 2021.

Serge, nor any peers, have made any analyst calls on VRCA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources